KROS
#3599
Keros Therapeutics, Inc. - common stock
10.5 0 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.66%
Variación mensual
+2.44%
Variación en los últimos 6 meses
-45.05%
Cambio anual
-30.46%
Cierres anteriores
10.5 7
Open
10.6 0
Mínimo
10.3 7
High
10.6 9
Volumen
42
Financials
- Market Capitalization 207.81 M
- Employee 87
- Founded 2015
- CEO N/A
- Website www.kerostx.com
- Headquarter Massachusetts, United States
- FIGI BBG00H1HP9G9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.36
Relación precio/flujo de caja
13.69
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3592 |  AGEN Agenus Inc. - Common Stock | 4.97 USD | -2.17% | +43.23% | +52.45% | -20.86% | 206.96 M USD | ||
| 3595 |  SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 75.39 USD | 0.00% | -4.57% | +3.26% | +843.55% | 210.05 M USD | ||
| 3601 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 1.73 USD | 0.00% | +21.83% | +45.38% | +319.39% | 209.09 M USD | ||
| 3602 |  RNA Atrium Therapeutics, Inc. - Common Stock | 12.22 USD | 0.00% | -6.50% | -4.16% | -82.62% | 209.03 M USD |